| Net income | -13.16M |
| Depreciation and amortization | 6M |
| Bad debt expense | 327K |
| Inventory reserves | 514K |
| Non-cash interest expense | 138K |
| Stock options compensation expense | |
| Stock issued in lieu of directors fees | |
| Deferred income taxes | -268K |
| Accounts and notes receivable | -303K |
| Inventory | -1.32M |
| Prepaid expenses and interest receivable | |
| Other assets | |
| Accounts payable | 427K |
| Other current liabilities | |
| Deferred revenues | -554K |
| Income taxes | |
| Other long-term liabilities | |
| Net cash (used in) provided by operating activities: | -803K |
| Purchase of property and equipment | -789K |
| Purchase of intangible and other assets | |
| Purchase of investment | |
| Net cash used in investing activities | -2.45M |
| Fees paid for credit facility | |
| Proceeds from exercise of common stock options | |
| Purchase of treasury stock | |
| Principal payments on capital lease obligations | 0 |
| Proceeds from credit facility | |
| Principal payments on notes payable and debt | |
| Net cash provided by (used in) financing activities: | -3.16M |
| Effect of exchange differences on cash | |
| Net increase in cash and cash equivalents | -6.41M |
| Cash and cash equivalents at beginning of period | 16.24M |
| Cash and cash equivalents at end of period | 9.82M |
| Interest | 1.05M |
| Income taxes | 6K |